Choline, CDP-choline or phosphocholine increases plasma glucagon in rats: Involvement of the peripheral autonomic nervous system

European Journal of Pharmacology

Volumn 589, Issue 1-3, 2008, Pages 315-322

  Cansev, Mehmet ^a   Ilcol, Yesim Ozarda ^a   Yilmaz, Mustafa Sertac ^a   Hamurtekin, Emre ^a   Ulus, Ismail H ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Adrenoceptor; Catecholamine; CDP choline; Choline; Glucagon; Phosphocholine

Indexed keywords

ATROPINE METHYL NITRATE; CHOLINE; CITICOLINE; GLUCAGON; HEMICHOLINIUM 3; HEXAMETHONIUM; MECAMYLAMINE; PHOSPHORYLCHOLINE;

ADRENALECTOMY; ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; GLUCAGON BLOOD LEVEL; GLUCAGON RELEASE; MALE; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENAL MEDULLA; ADRENALECTOMY; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AUTONOMIC NERVOUS SYSTEM; BRAIN; CHOLINE; CYTIDINE DIPHOSPHATE CHOLINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GANGLIONIC BLOCKERS; GLUCAGON; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MALE; MUSCARINIC ANTAGONISTS; NEUROTRANSMITTER UPTAKE INHIBITORS; NICOTINIC ANTAGONISTS; PHOSPHORYLCHOLINE; RATS; RATS, SPRAGUE-DAWLEY; SYMPATHECTOMY, CHEMICAL; TIME FACTORS; UP-REGULATION;

EID: 47549099175     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.05.017     Document Type: Article

References (41)

1. Adibhatla R.M., and Hatcher J.F. Cytidine 5′-diphosphocholine (CDP-Choline) in stroke and other CNS disorders. Neurochem. Res. 30 (2005) 15-23
2. Ahren B. Autonomic regulation of islet hormone secretion-implications for health and disease. Diabetologia 43 (2000) 393-410
3. Ahren B., and Lundquist I. Alpha-adrenoceptor blockade by phentolamine inhibits beta-adrenergically and cholinergically induced glucagon secretion in the mouse. Horm. Metab. Res. 19 (1987) 600-603
4. Alkondon M., and Albuquergue E.X. Subtype-specific inhibition of nicotinic acetylcholine receptors by choline: a regulatory pathway. J. Pharmacol. Exp. Ther. 318 (2006) 268-275
5. Alkondon M., Pereira E.F.R., Cortes W.S., Maelicke A., and Albuquergue E.X. Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons. Eur. J. Neurosci. 9 (1997) 2734-2742
6. Arslan B.Y., Ulus I.H., Savci V., and Kiran B.K. Effects of intracerebroventricular injected choline on cardiovascular functions and sympathoadrenal activity. J. Cardiovasc. Pharmacol. 17 (1991) 814-821
7. Cansev M. Uridine and cytidine in the brain: their transport and utilization. Brain Res. Rev. 52 (2006) 389-397
8. Cansev M., Yilmaz M.S., Ilcol Y.O., Hamurtekin E., and Ulus I.H. Cardiovascular effects of CDP-choline and its metabolites: involvement of peripheral autonomic nervous system. Eur. J. Pharmacol. 577 (2007) 129-142
9. Cansev M., Ilcol Y.O., Yilmaz M.S., Hamurtekin E., and Ulus I.H. Peripheral administration of CDP-choline, phosphocholine or choline increases plasma adrenaline and noradrenaline concentrations. Auton. Autocaid Pharmacol. 28 (2008) 41-58
10. Cavun S., Savci V., and Ulus I.H. Centrally injected CDP-choline increases plasma vasopressin levels by central cholinergic activation. Fundam. Clin. Pharmacol. 18 (2005) 71-77
11. Dieterich H.A., Lindmar R., and Loffelholz K. The role of choline in the release of acetylcholine in isolated hearts. Naunyn-Schmiedeberg's Arch. Pharmacol. 301 (1978) 207-215
12. Gilon P., and Henquin J.-C. Mechanisms and physiological significance of the cholinergic control of pancreatic b-cell function. Endocr. Rev. 22 (2001) 565-604
13. Gurun M.S., Ilcol Y.O., Taga Y., and Ulus I.H. Hyperglycemia induced by intracerebroventricular choline: involvement of the sympatho-adrenal system. Eur. J. Pharmacol. 438 (2002) 197-205
14. Holst J.J., Schaffalitzky de Muckadell O.B., Fahrenkrug J., Lindkaer S., Nielsen O.V., and Schwartz T.W. Nervous control of pancreatic endocrine secretion in pigs. The effect of acetylcholine on the pancreatic secretion of insulin and glucagon. Acta Physiol. Scand. 111 (1981) 15-22
15. Iguchi A., Gotoh M., Matsunaga H., Yatomi A., Honmura A., Yanase M., and Sakamoto N. Relative contributions of the nervous system and hormones to CNS-mediated hyperglycemia. Am. J. Physiol. 255 (1988) E920-E927
16. Iguchi A., Gotoh M., Matsunaga H., Yatomi A., Uemura K., Miura H., Satake T., Tamagawa T., and Sakamoto N. Central-nervous system mediated glucagon secretion is enhanced by alpha2-adrenoceptor activation. Endocrinology 125 (1989) 1581-1586
17. Ilcol Y.O., Gurun M.S., Taga Y., and Ulus I.H. Intraperitoneal administration of choline increases serum glucose in rat: involvement of the sympatho-adrenal system. Horm. Metab. Res. 34 (2002) 341-347
18. Ilcol Y.O., Gurun M.S., Taga Y., and Ulus I.H. Choline increases serum insulin in rat when injected intraperitoneally and augments basal and stimulated acetylcholine release from the rat minced pancreas in vitro. Eur. J. Biochem. 270 (2003) 991-999
19. Ilcol Y.O., Ozbek R., Hamurtekin E., and Ulus I.H. Choline status in newborns, infants, children, breast-feeding women, breast-fed infants and human breast milk. J. Nutr. Biochem. 16 (2005) 489-499
20. Ilcol Y.O., Cansev M., Yilmaz M.S., Hamurtekin E., and Ulus I.H. Intraperitoneal administration of CDP-choline and its cholinergic and pyrimidinergic metabolites induce hyperglycemia in rats: involvement of the sympathoadrenal system, Arch. Physiol. Biochem. 113 (2007) 186-201
21. Ilcol Y.O., Cansev M., Yilmaz M.S., Hamurtekin E., and Ulus I.H. Peripheral administration of CDP-choline and its cholinergic metabolites increases serum insulin: muscarinic and nicotinic acetylcholine receptors are both involved in their actions. Neurosci. Lett. 431 (2008) 71-76
22. Karlsson S., and Ahren B. Insulin and glucagon secretion in swimming mice: effects of autonomic receptor antagonism. Metabolism 39 (1990) 724-732
23. Karlsson S., and Ahren B. Muscarinic receptor subtypes in carbachol-stimulated insulin and glucagon secretion in mouse. J. Auton. Pharm. 13 (1993) 439-440
24. Karlsson S., and Ahren B. Insulin and glucagon secretion by ganglionic nicotinic activation in adrenalectomized mice. Eur. J. Pharmacol. 342 (1998) 291-295
25. Knudtzon J. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits-influences of selective blocking drugs. Acta Physiol. Scand. 120 (1984) 353-361
26. Lacey R.L., Berrow N.S., Scarpello J.H., and Morgan N.G. Selective stimulation of glucagon secretion by beta 2-adrenoceptors in isolated islets of Langerhans of the rat. Br. J. Pharmacol. 103 (1991) 1824-1828
27. Lopez G-Coviella I., Agut J., and Wurtman R.J. Metabolism of cytidine (5′) diphosphocholine (CDP-choline) following oral and intravenous administration to the human and the rat. Neurochem. Int. 11 (1987) 293-297
28. Meyer E.M., and Baker S.P. Effects of choline augmentation on acetylcholine release in rat atrial minces. Life Sci. 39 (1986) 1307-1315
29. Saito M., Saitoh T., and Inoue S. Alpha 2-adrenergic modulation of pancreatic glucagons secretion in rats. Physiol. Behav. 51 (1992) 1165-1171
30. Savci V., Goktalay G., Cansev M., Yilmaz M.S., and Ulus I.H. Intravenously injected CDP-choline increases blood pressure and reverses hypotension in haemorrhagic shock: effect is mediated by central cholinergic activation. Eur. J. Pharmacol. 468 (2003) 129-139
31. Secades J.J., and Lorenzo J.L. Citicoline: pharmacological and clinical review. Methods Find. Exp. Clin. Pharmacol. 28 Suppl B (2006) 1-56
32. Seddik R., Bradaia A., and Trouslard J. Choline induces Ca2+ entry in cultural sympathetic neurons isolated from rat superior cervical ganglion. Eur. J. Pharmacol. 471 (2003) 165-176
33. Skoglund G., Lundquist I., and Ahren B. Alpha 1- and alpha 2-adrenoceptor activation increases plasma glucagon levels in the mouse. Eur. J. Pharmacol. 143 (1987) 83-88
34. Ulus I.H., and Wurtman R.J. Selective response of rat peripheral sympathetic nervous system to various stimuli. J. Physiol. 293 (1979) 513-523
35. Ulus I.H., Hirsch M.J., and Wurtman R.J. Trans-synaptic induction of adrenomedullary tyrosine hydroxylase activity by choline: evidence that choline administration can increase cholinergic transmission. Proc. Natl. Acad. Sci. U. S. A. 74 (1977) 798-800
36. Ulus I.H., Scally M.C., and Wurtman R.J. Enhancement by choline of the induction of adrenal tyrosine hydoxylase by phenoxybenzamine, 6-hydroxydopamine, insulin or exposure to cold. J. Pharmacol. Exp. Ther. 204 (1978) 676-682
37. Ulus I.H., Millington W.R., Buyukuysal R.L., and Kiran B.K. Choline as an agonist: determination of its agonistic potency on cholinergic receptors. Biochem. Pharmacol. 14 (1988) 2747-2755
38. Ulus I.H., Arslan B.Y., Savci V., and Kiran B.K. Restoration of blood pressure by choline treatment in rats made hypotensive by haemorrhage. Br. J. Pharmacol. 116 (1995) 1911-1917
39. Verspohl E.J., Tacke R., Mutscher E., and Lambrecht G. Muscarinic receptor subtypes in rat pancreatic islets: binding and functional studies. Eur. J. Pharmacol. 178 (1990) 303-311
40. Wurtman R.J., Regan M., Ulus I., and Yu L. Effect of oral CDP-choline on plasma choline and uridine levels in humans. Biochem. Pharmacol. 60 (2000) 989-992
41. Zwart R., and Vijverberg H.P. Potentiation and inhibition of neuronal alpha4beta4 nicotinic acetylcholine receptors by choline. Eur. J. Pharmacol. 393 (2000) 209-214